Details

New Rapid-acting Antidepressants


New Rapid-acting Antidepressants


Contemporary Clinical Neuroscience

von: Kenji Hashimoto, Mario Manto

171,19 €

Verlag: Springer
Format: PDF
Veröffentl.: 22.10.2021
ISBN/EAN: 9783030797904
Sprache: englisch
Anzahl Seiten: 149

Dieses eBook enthält ein Wasserzeichen.

Beschreibungen

<div>​This book discusses new candidates for rapid-acting antidepressants,&nbsp;such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3&nbsp;antagonists and AMPA receptor agonists.&nbsp; There are serious limitations&nbsp;to currently available antidepressants, such as delayed onset and low&nbsp;rates of efficacy.&nbsp; The discovery that a single dose of ketamine, an&nbsp;NMDAR antagonist, can produce rapid antidepressant effects that are&nbsp;sustained has led to new research in this area.&nbsp; In this volume, a&nbsp;variety of novel pharmaceutical treatments are examined.&nbsp; This volume&nbsp;would be useful to both researchers and clinicians who work in the field&nbsp;of pharmacology, specifically CNS drug treatments.<br></div>
(<i>R</i>)-ketamine: A new rapid-acting antidepressant.-&nbsp;(2<i>R</i>,6<i>R</i>)-hydroxynorketamine, a metabolite of ketamine: the antidepressant actions and the mechanisms.-&nbsp;Predictable biomarkers for rapid-acting antidepressant response to ketamine.-&nbsp;Nitrous Oxide: an old compound with emerging psychotropic properties.-&nbsp;Novel AMPA receptor potentiators TAK-137 and TAK-653 as potential rapid-acting antidepressants.-&nbsp;AMPA receptor potentiators as potential rapid-acting antidepressants.-&nbsp;mGlu2/3 receptor antagonists as rapid-acting antidepressants.-&nbsp;Antidepressant effects of the muscarinic receptor antagonist scopolamine: Clinical and preclinical review.
<p>First Name – Kenji <br> Last Name – Hashimoto<br> Institution - Chiba University Center for Forensic Mental Health<br> Department - Division of Clinical Neuroscience<br> City – Chiba 260-8670<br> State – Chiba<br> Country – Japan<br> Email –&nbsp;hashimoto@faculty.chiba-u.jp<br> <br> <b></b></p>

<p><br></p>

<p>Kenji Hashimoto, PhD</p>

Chiba University,&nbsp;Chiba, Japan<p></p>

<p>Dr. Hashimoto is a professor and vice-director of Chiba University Center for Forensic Mental Health from 2005. Dr. Hashimoto graduated from Faculty of Pharmaceutical Sciences at Kyushu University, and received PhD. After Dr. Hashimoto worked at Fukuyama University, National Institutes of Health (NIH)/National Institute of Drug Addiction (NIDA)(Baltimore, MD, USA) and Pharmaceutical company, he moved at Chiba University Graduate School of Medicine from 2001. Dr. Hashimoto works on the development of novel therapeutic drugs for psychiatric and neurological disorders. Dr. Hashimoto published more than 550articles in PubMed listed publications. Dr. Hashimoto focus on the molecular and cellular mechanisms of ketamine’s antidepressant actions.</p><br><p></p>
This book discusses new candidates for rapid-acting antidepressants,&nbsp;such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3&nbsp;antagonists and AMPA receptor agonists.&nbsp; There are serious limitations&nbsp;to currently available antidepressants, such as delayed onset and low&nbsp;rates of efficacy.&nbsp; The discovery that a single dose of ketamine, an&nbsp;NMDAR antagonist, can produce rapid antidepressant effects that are&nbsp;sustained has led to new research in this area.&nbsp; In this volume, a&nbsp;variety of novel pharmaceutical treatments are examined.&nbsp; This volume&nbsp;would be useful to both researchers and clinicians who work in the field&nbsp;of pharmacology, specifically CNS drug treatments.<div><br></div><div>Discusses new candidate for rapid-acting antidepressants<div><br></div><div>Provides information for those who work in the field of CNS drugs</div><div><br></div><div>Ideal for pharmacologists, psychiatrists, and those who want to learnabout CNS drugs at the graduate level</div></div>
Discusses new candidate for rapid-acting antidepressants Provides information for those who work in the field of CNS drugs Ideal for pharmacologists, psychiatrists, and those who want to learn about CNS drugs at the graduate level

Diese Produkte könnten Sie auch interessieren:

Neural Engineering
Neural Engineering
von: Bin He
PDF ebook
109,99 €
Glutamate Receptors in Peripheral Tissue
Glutamate Receptors in Peripheral Tissue
von: Santokh Gill, Olga Pulido
PDF ebook
213,99 €
Neural Cell Behavior and Fuzzy Logic
Neural Cell Behavior and Fuzzy Logic
von: Uziel Sandler, Lev Tsitolovsky
PDF ebook
149,79 €